Campbell & Co Investment Adviser’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Campbell & Co Investment Adviser's ATRC Position: Q1 2026 in Review
Campbell & Co Investment Adviser sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 23,082 shares — an estimated $913K sold.
Campbell & Co Investment Adviser first reported a position in ATRC in Q3 2017 and held it in 11 quarters. The position peaked at $982K in Q1 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Campbell & Co Investment Adviser reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 23,082 AtriCure shares in Q1 2026, an estimated $913K.
- Campbell & Co Investment Adviser first reported a position in AtriCure in Q3 2017 and held it in 11 quarters.
- Campbell & Co Investment Adviser's AtriCure position peaked at $982K in Q1 2023.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.